Cellectis to Report Third Quarter 2024 Financial Results on November 4, 2024

2 weeks ago

NEW YORK, Oct. 30, 2024 ( GLOBE NEWSWIRE ) -- Cellectis ( the "Company" ) ( Euronext Growth: ALCLS- NASDAQ: CLLS ) , a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that it will report financial ...

Ticker	Sentiment	Impact
CLLS	Somewhat Bullish	93 %